Browsing Tag
Biotech
7 posts
Radyus Research and Dt&CRO Join Forces to Pave Way for South Korean Biotech Companies Into the U.S. Market
Radyus Research, a global drug development organization from Atlanta, Georgia, is excited to announce a pivotal strategic partnership…
VERO Biotech’s Second Generation GENOSYL® Delivery System (DS) Receives FDA Approval in Anesthesia in the Surgical Suite
Second Generation GENOSYL® DS is the first and only Inhaled Nitric Oxide delivery system that is FDA-approved for…
North America’s Largest lntegrated Research Site Organization, Centricity Research, Expands Further with Addition of Aventiv Research
North America’s clinical research leader, Centricity Research, announced that Aventiv Research has merged with the organization, extending the…
Softwave® Tissue Regeneration Technologies Announces Landmark Trial for Acute Traumatic Spinal Cord Injuries
SoftWave® Tissue Regeneration Technologies, a disruptive bio-medical device company, announces the beginning of a trial for "Extracorporeal Shock Wave Therapy in Acute Traumatic Complete and Incomplete Cross - Sectional Lesions." The trial will be sponsored by the Austrian Workers' Compensation Board (AUVA). It will be conducted in 13 hospitals in Austria and one in Germany, over the next two years.
Expression Therapeutics Announces Bill Swaney as VP of Manufacturing and the Construction of Cell and Gene Therapy Manufacturing
Expression Therapeutics has announced the appointment of Bill Swaney as the Vice President of Manufacturing. He comes to Expression Therapeutics from the Cincinnati Children's Hospital Medical Center where he was the Director of the Vector Production Facility & Viral Vector Core. Mr. Swaney is an internationally recognized expert in GMP cell and gene therapy manufacturing and has conducted over 70 GMP production runs for academic and commercial clients.
VERO Biotech to Present at Biotech Showcase 2020
VERO Biotech LLC, an Atlanta, Georgia-based biotechnology company focused on saving lives, alleviating suffering and improving the healthcare economics, is pleased to announce it will be presenting at Biotech Showcase 2020. Biotech Showcase 2020 will take place concurrently with the 38(th) annual J.P. Morgan Healthcare Conference.
Gregory Robinson Joins Nonprofit Biotech Odylia Therapeutics Advisory Board
Gregory Robinson, Ph.D., joins the Advisory Board of Odylia Therapeutics, a nonprofit biotech dedicated to bringing treatments for rare disease to patients. He is the Chief Science Officer at Akouos and brings to Odylia extensive biotech experience in gene therapy, ophthalmology, and the rare disease space.